Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Pascual

Showing results (11-20 of 212) with videos related to

Pageof 22
Sort By:
Transplant Immunology|September 9, 2008
Minimization of calcineurin inhibitors to improve long-term outcomes in kidney transplantationDela Golshayan, Manuel Pascual
Transplant International : Official Journal of the European Society for Organ Transplantation|October 5, 2006
Drug-minimization or tolerance-promoting strategies in human kidney transplantation: is Campath-1H the way to follow?Dela Golshayan, Manuel Pascual
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 11, 2005
Humoral rejection of organ allograftsSolange Moll, Manuel Pascual
Archives of Internal Medicine|July 14, 2004
Update in renal transplantationColm C Magee, Manuel Pascual
Expert Opinion on Investigational Drugs|April 28, 2007
New treatments for acute humoral rejection of kidney allograftsJean-Pierre Venetz, Manuel Pascual
Transplant International : Official Journal of the European Society for Organ Transplantation|April 12, 2007
Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantationDonatella Ciuffreda, Giuseppe Pantaleo, Manuel Pascual
Expert Review of Anti-Infective Therapy|October 28, 2011
Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantationOriol Manuel, Nancy Perrottet, Manuel Pascual
Expert Review of Clinical Immunology|July 31, 2014
Potential and limitations of regulatory T-cell therapy in solid organ transplantationLerisa Govender, Manuel Pascual, Dela Golshayan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2006
Preemptive versus prophylactic approaches in the management of cytomegalovirus disease in solid organ transplant recipients: what we know and what we do not knowPascal R-A Meylan, Manuel Pascual
Kidney International. Supplement|December 1, 2010
Infection and chronic allograft dysfunctionPeter J Dupont, Oriol Manuel, Manuel Pascual
Pageof 22

Showing results (11-20 of 212) with videos related to

Sort By:
Pageof 22
Transplant Immunology|September 9, 2008
Minimization of calcineurin inhibitors to improve long-term outcomes in kidney transplantationDela Golshayan, Manuel Pascual
Transplant International : Official Journal of the European Society for Organ Transplantation|October 5, 2006
Drug-minimization or tolerance-promoting strategies in human kidney transplantation: is Campath-1H the way to follow?Dela Golshayan, Manuel Pascual
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 11, 2005
Humoral rejection of organ allograftsSolange Moll, Manuel Pascual
Archives of Internal Medicine|July 14, 2004
Update in renal transplantationColm C Magee, Manuel Pascual
Expert Opinion on Investigational Drugs|April 28, 2007
New treatments for acute humoral rejection of kidney allograftsJean-Pierre Venetz, Manuel Pascual
Transplant International : Official Journal of the European Society for Organ Transplantation|April 12, 2007
Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantationDonatella Ciuffreda, Giuseppe Pantaleo, Manuel Pascual
Expert Review of Anti-Infective Therapy|October 28, 2011
Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantationOriol Manuel, Nancy Perrottet, Manuel Pascual
Expert Review of Clinical Immunology|July 31, 2014
Potential and limitations of regulatory T-cell therapy in solid organ transplantationLerisa Govender, Manuel Pascual, Dela Golshayan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2006
Preemptive versus prophylactic approaches in the management of cytomegalovirus disease in solid organ transplant recipients: what we know and what we do not knowPascal R-A Meylan, Manuel Pascual
Kidney International. Supplement|December 1, 2010
Infection and chronic allograft dysfunctionPeter J Dupont, Oriol Manuel, Manuel Pascual
Pageof 22